About Dr. Jung Seung Pil
- Dr. Jung Seung Pil is a Seoul-based Surgical Oncologist with 17+ years in the field.
- He is a member of the American Society of Breast Surgeon, Ethics Committee of Korean Breast Cancer Society, and Academic committee of Korean Breast cancer Society.
- He is also the Director of the Academic Committee of the Korean Association of Breast Surgery, Editor of Journal of Breast Disease, and Annals of Surgical Treatment and Research.
- He completed his M.D. in Medical Science from the Korea University College of Medicine, Seoul, South Korea in 2003 and M.S, from the same university in 2007.
- He completed his Ph.D. in Medicine (Surgery) in 2011 from the Korea University College of Medicine, Seoul, South Korea.
- Dr. Jung's areas of expertise include breast cancer surgery, reconstructive breast surgery, high-resolution breast sonography, high-speed biopsy, aesthetic breast surgery, etc.
- He has authored more than 50 publications in various scientific national and international journals of repute.
Hospital
Korea University – Anam HospitalLocation
Seoul, South KoreaSpecial Interest
High-resolution breast sonography High-speed biopsy Reconstructive breast surgery Aesthetic breast surgery Chemotherapy and immunotherapy
Work Experience of Dr. Jung Seung Pil
Dr. Jung Seung Pil's
- Graduation, 2003, Korea University College of Medicine, Seoul, South Korea
- Post Graduation, 2007, Korea University College of Medicine, Seoul, South Korea
2018.03.21: Commendation of Korean Minister of Health and Welfare for cancer prevention 2018.09.30: Taipei International Breast Cancer Symposium, Great Paper Award
- EGFR is a Therapeutic Target in Hormone Receptor-Positive Breast Cancer
- Neoadjuvant Chemotherapy and Prognosis of Pregnancy-Associated Breast Cancer: A Time-Trends Study of the Korean Breast Cancer Registry Database 2018.12
- Differences in prognosis and efficacy of chemotherapy by p53 expression in triple-negative breast cancer 2018.11
- Clinical subtypes and prognosis of pregnancy-associated breast cancer: results from the Korean Breast Cancer Society Registry database 2018.11
- Fibronectin expression is upregulated by PI-3K/Akt activation in tamoxifen-resistant breast cancer cells 2017.12
(Get Free opinion, Quote, Medical Visa Invitation and Assistance at every step of your treatment.)
Doctor Similar to Dr. Jung Seung Pil in Seoul
Surgical Oncologist
Professor
Graduation,MS
Seoul, South Korea
32 years of experience
Surgical Oncologist
Professor
Graduation,MD,MS
Seoul, South Korea
32 years of experience
The Catholic University Of Korea – Seoul St. Mary’s Hospital
Surgical Oncologist
Associate Professor
Graduation
Seoul, South Korea
22 years of experience
Surgical Oncologist
Professor
Graduation,MS
Seoul, South Korea
24 years of experience
Surgical Oncologist
Associate Professor
Graduation,Post Graduation
Seoul, South Korea
15 years of experience
Surgical Oncologist
Associate Professor
Graduation,MS
Seoul, South Korea
12 years of experience
The Catholic University Of Korea – Seoul St. Mary’s Hospital
Surgical Oncologist
Consultant
Graduation,MS
Seoul, South Korea
11 years of experience